Planet 13 Holdings (PLNH) Other Non Operating Income (2021 - 2025)
Planet 13 Holdings (PLNH) posted quarterly Other Non Operating Income of -$224.0 for Q2 2025, up 96.77% year-over-year from -$113.84 in Q2 2024, and up 92.25% quarter-over-quarter from -$2889.0 in Q1 2025.
Planet 13 Holdings (PLNH) Other Non Operating Income (2021 - 2025) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Other Non Operating Income for 5 consecutive years, with -$224.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Other Non Operating Income rose 96.77% year-over-year to -$224.0; the TTM figure through Mar 2026 stood at -$224.0 (up 98.48% YoY), while the FY2025 annual figure was -$3113.0, up 79.17% from the prior year.
- Other Non Operating Income improved to -$224.0 in Q2 2025 per PLNH's latest filing, from -$2889.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $4.4 million in Q4 2021 and bottomed at -$6945.0 in Q2 2024.
- Historically, Other Non Operating Income has averaged $631173.2 across 5 years, with a median of $3058.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 59950.79% — and 2024, when it tumbled 1610.34%.
- Planet 13 Holdings' Other Non Operating Income stood at $4.4 million in 2021, then plunged by 100.06% to -$2528.0 in 2022, then jumped by 59950.79% to $1.5 million in 2023, then tumbled by 100.12% to -$1834.0 in 2024, then jumped by 87.79% to -$224.0 in 2025.
- Business Quant data shows PLNH's Other Non Operating Income at -$224.0 in Q2 2025, -$2889.0 in Q1 2025, and -$1834.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Planet 13 Holdings | 54.56 Mn | 38.08 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -308,362.00 |
| Jun 30, 2025 | -224.00 |
| Mar 31, 2025 | -2,889.00 |
| Dec 31, 2024 | -1,834.00 |
| Sep 30, 2024 | -3,066.00 |
| Jun 30, 2024 | -6,945.00 |
| Mar 31, 2024 | -3,097.00 |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 203.00 |
| Jun 30, 2023 | 4,229.00 |
| Mar 31, 2023 | 1,887.00 |
| Dec 31, 2022 | -2,528.00 |
| Sep 30, 2022 | 197,721.00 |
| Jun 30, 2022 | 74,543.00 |
| Mar 31, 2022 | 4.16 Mn |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | 79,688.00 |
| Jun 30, 2021 | 896,630.00 |
| Mar 31, 2021 | 62,897.00 |